Community pharmacists' perspectives on E-pharmacy: an imminent threat or an opportunity in disguise?

社区药剂师对电子药房的看法:迫在眉睫的威胁还是伪装的机遇?

阅读:1

Abstract

BACKGROUND: E-pharmacy has transformed healthcare delivery, enhancing access and affordability, yet its impact on community pharmacists remains debatable. Although these advancements improve efficiency and reduce errors, they limit pharmacist-patient interactions, raising concerns about medication adherence and healthcare quality. OBJECTIVE: This study assessed community pharmacists' perceptions of e-pharmacy as a potential threat or opportunity. It explored the challenges, barriers, and opportunities it presents and its impact on professional roles, business sustainability, and patient care. METHODS: A cross-sectional questionnaire-based study was conducted between June and September 2024 among licensed community pharmacists. A total of 305 pharmacists participated. Chi-square (χ(2)) and Spearman's rank correlation tests examined differences in pharmacists' perceptions of e-pharmacy using SPSS version 24, with statistical significance set at p < 0.05. RESULTS: Significant associations were observed between demographic variables and pharmacists' perceptions of e-pharmacy. A significant association was found between age and perceptions of e-prescribing challenges (χ(2) = 10.85, p = 0.012, V = 0.19), with pharmacists over 50 years showing greater concern (75.0%). Pharmacists in chain pharmacies demonstrated more favorable attitudes (62.7%) than those in private pharmacies (59.5%) (χ(2) = 8.24, p = 0.016, V = 0.16). Younger pharmacists (20-30 years) held more positive attitudes toward e-pharmacy than those over 50 (χ(2) = 12.14, p = 0.007, V = 0.20). CONCLUSION: Community pharmacists play a vital role in mitigating e-pharmacy errors and adapting to digital workflows. Policymakers must partner with pharmacists to enhance efficiency while preserving their essential role in patient care. Although conducted in the Aseer region, these findings provide exploratory insights that may inform, rather than represent, broader national discussions on e-pharmacy regulation and integration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。